sellWeak10b5-1 plan
EDGEMOND JAMES sold $2.8M of UTHR
CFO AND TREASURER at UNITED THERAPEUTICS Corp. 7,792 shares at an average of $355.88, traded Oct 14, 2024, filed Oct 15, 2024.
Warning score
32Value
$2.8M
7,792 shares
Holdings after
6,426
-85% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-025121, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 14, 2024 | MOption exercise Common Stock10b5-1 | +3,267 | $120.26 | $393k | 9,151 | Oct 15, 2024 |
| Oct 14, 2024 | SOpen-market sale Common Stock10b5-1 | -3,267 | $355.88 | $1.2M | 5,884 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Common Stock10b5-1 | +3,400 | $177.76 | $604k | 9,284 | Oct 15, 2024 |
| Oct 14, 2024 | SOpen-market sale Common Stock10b5-1 | -3,400 | $355.88 | $1.2M | 5,884 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Common Stock10b5-1 | +817 | $120.26 | $98k | 6,701 | Oct 15, 2024 |
| Oct 14, 2024 | SOpen-market sale Common Stock10b5-1 | -553 | $355.88 | $197k | 6,148 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Common Stock10b5-1 | +850 | $117.76 | $100k | 6,998 | Oct 15, 2024 |
| Oct 14, 2024 | SOpen-market sale Common Stock10b5-1 | -572 | $355.88 | $204k | 6,426 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Stock Optionsderivative10b5-1 | -3,267 | $0.00 | $0 | 13,069 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Stock Optionsderivative10b5-1 | -3,400 | $0.00 | $0 | 125,100 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Stock Optionsderivative10b5-1 | -817 | $0.00 | $0 | 12,252 | Oct 15, 2024 |
| Oct 14, 2024 | MOption exercise Stock Optionsderivative10b5-1 | -850 | $0.00 | $0 | 124,250 | Oct 15, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $640k | 2,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.0M | 9,679 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.